France Braces for Continued Flu Season Decline, Vigilance Remains Key
Recent data from Santé publique France indicates a continuing downward trend in flu cases across France as of February 11, 2026. While the peak appears to have passed, health officials are emphasizing the importance of sustained vigilance, particularly regarding vaccination and monitoring emerging viral strains.
Flu Trends: A Regional Overview
Nationwide, the incidence of flu-like illnesses is decreasing in both urban and hospital settings, currently categorized as a low-intensity level. However, regional variations persist. Auvergne-Rhône-Alpes has transitioned into a post-epidemic phase, while other regions remain in an epidemic state. Overseas territories like the Antilles and French Guiana continue to experience ongoing epidemic activity.
The decline is reflected in key indicators: consultations for flu-like syndromes are down, hospital emergency room visits related to the flu are decreasing and the proportion of positive flu tests is falling across all testing environments – laboratories, general practice, and hospitals.
Did you know? 71% of severe flu cases requiring hospitalization among those with known vaccination history were unvaccinated.
Viral Landscape: A(H3N2) Dominance
The predominant circulating influenza strains are type A viruses. Specifically, A(H3N2) accounts for the majority (59.7%) of typed A viruses in hospital settings, while A(H1N1)pdm09 represents 40.3%. In urban settings, A(H3N2) accounts for 57.2% of cases, with A(H1N1)pdm09 at 35.8%.
Genetic sequencing reveals that the dominant sub-clade for A(H3N2) is K (96%), and for A(H1N1)pdm09, it’s D.3.1.1 (92%). This ongoing genomic surveillance is crucial for tracking viral evolution and assessing vaccine effectiveness.
Bronchiolitis: Stable but Persistent
While flu activity is waning, bronchiolitis indicators show a slight increase in urban areas, remaining near levels observed during the same period last year. Hospital data indicates a slight decrease in emergency room visits but a rise in hospitalizations following those visits. Bronchiolitis indicators remain at baseline levels.
The rate of Respiratory Syncytial Virus (RSV) positivity remains elevated compared to the previous season, indicating continued circulation of the virus.
COVID-19: Stable and Low-Level
COVID-19 indicators remain stable and at low levels both in urban and hospital settings. Wastewater surveillance suggests a slight increase in SARS-CoV-2 detection, but levels remain low. The proportion of deaths certified as being due to COVID-19 is decreasing.
Vaccination Coverage: A Positive Trend
Vaccination coverage against influenza is showing improvement compared to last year, with 46.3% of the target population vaccinated as of December 31, 2025. Coverage among those 65 and older is 53.3%, while coverage for those under 65 at risk of severe flu is 27.1%.
Healthcare Facility Outbreaks
There were 77 fresh outbreaks of acute respiratory infections in healthcare facilities during week 05 (data not fully consolidated). The majority (42) were attributed solely to influenza, with 2 to RSV and 12 to COVID-19.
FAQ
Q: Is the flu season over in France?
A: While the peak has passed and cases are declining, the flu season is not yet over. Vigilance and continued monitoring are essential.
Q: What type of flu is currently circulating?
A: Type A viruses, particularly A(H3N2), are dominant.
Q: Is the flu vaccine effective against the current strains?
A: Early estimates suggest the vaccine offers protection, but effectiveness varies. Vaccination remains the best defense.
Q: What should I do if I experience flu-like symptoms?
A: Consult a healthcare professional for diagnosis and treatment.
Pro Tip: Regular handwashing and respiratory etiquette (covering coughs and sneezes) remain crucial for preventing the spread of respiratory infections.
Explore further: Read the full report from Santé publique France.
Stay informed: Sign up for our newsletter to receive the latest updates on public health trends and preventative measures.
